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Necrotic enteritis in broiler chickens is associated with netB positive Clostridium perfringens type A strains. It is
known that C. perfringens strains isolated from outbreaks of necrotic enteritis are more capable of secreting factors
inhibiting growth of other C. perfringens strains than strains isolated from the gut of healthy chickens. This
characteristic could lead to extensive and selective presence of a strain that contains the genetic make-up enabling
to secrete toxins that cause gut lesions. This report describes the discovery, purification, characterization and
recombinant expression of a novel bacteriocin, referred to as perfrin, produced by a necrotic enteritis-associated
netB-positive C. perfringens strain. Perfrin is a 11.5 kDa C-terminal fragment of a 22.9 kDa protein and showed no
sequence homology to any currently known bacteriocin. The 11.5 kDa fragment can be cloned into Escherichia coli,
and expression yielded an active peptide. PCR detection of the gene showed its presence in 10 netB-positive C.
perfringens strains of broiler origin, and not in other C. perfringens strains tested (isolated from broilers, cattle, sheep,
pigs, and humans). Perfrin and NetB are not located on the same genetic element since NetB is plasmid-encoded
and perfrin is not. The bacteriocin has bactericidal activity over a wide pH-range but is thermolabile and sensitive to
proteolytic digestion (trypsin, proteinase K). C. perfringens bacteriocins, such as perfrin, can be considered as an
additional factor involved in the pathogenesis of necrotic enteritis in broilers.Introduction
Enteric diseases are an important concern to the poultry
industry because of production losses, increased mortality,
reduced welfare of birds and increased risk of contamin-
ation of poultry products for human consumption. Nec-
rotic enteritis is a widespread disease in broilers imposing
a significant economic burden on the poultry industry
worldwide. The total global economic loss as a conse-
quence of necrotic enteritis outbreaks in broiler farms is
estimated to be over 2 billion dollars annually [1,2].
Clostridium perfringens type A is widely prevalent in the
environment and in the intestinal tract of animals and
humans. Necrotic enteritis in poultry is associated with a
specific subpopulation of C. perfringens type A, i.e. strains
carrying the NetB toxin [3,4]. As a consequence, strains* Correspondence: leen.timbermont@ugent.be
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article, unless otherwise stated.isolated from outbreaks of necrotic enteritis are able to in-
duce lesions in an experimental model using predisposing
factors, in contrast to strains isolated from the gut of
healthy broilers [5,6]. NetB resides in a large plasmid
encoded locus [7].
In C. perfringens isolates from healthy birds, a high de-
gree of genetic diversity can be found, even between iso-
lates within the gut of a single animal. In contrast, in a
flock suffering from a clinical outbreak, different isolates
are generally of the same pulsed-field gel electrophoresis
(PFGE) type, regardless of which animal in the flock or
which part of the intestine the strain is isolated from
[8,9]. Recent data show that C. perfringens is capable of
secreting factors inhibiting growth of other C. perfrin-
gens strains. The intra-species inhibitory phenotype was
shown to be more prevalent in outbreak strains com-
pared to strains isolated from the gut of healthy broilers
[10,11]. This characteristic could allow a single strain to
outcompete other C. perfringens strains in the gut, and ifntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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it could consequently cause gut lesions.
Many C. perfringens strains are able to produce antibac-
terial proteins, called bacteriocins [12]. Bacteriocins are
proteinaceous toxic compounds produced by bacteria that
generally inhibit the growth of closely related strains [13],
and are thus potential candidates involved in the intra-
species inhibitory phenotype of C. perfringens. The nature
of the inhibitory components that cause intra-species
growth-inhibition in broiler outbreak strains of C. perfrin-
gens was hitherto unknown. In the present study, we puri-
fied and characterized a novel antimicrobial peptide from
a C. perfringens outbreak strain with intra-species inhibitory
activity and showed it to be located on the chromosome
and specifically present in a selection of netB positive C.
perfringens strains from broilers.
Materials and methods
Strains
Fifty C. perfringens type A strains isolated from broiler
chickens belonging to different genotypes, as analyzed
by pulsed-field gel electrophoresis (PFGE), were in-
cluded. Thirty-five strains were isolated from broiler
chickens in Belgium: 26 strains from clinically healthy
broiler chickens and 9 strains from broilers suffering
from necrotic enteritis [9]. Fifteen Danish C. perfringens
isolates from necrotic enteritis cases were kindly pro-
vided by Dr L. Bjerrum [8]. C. perfringens strain 56 was
isolated from the intestine of a broiler chicken with
severe necrotic gut lesions. It was selected because it is a
virulent strain that inhibits the growth of 41 of the 50
strains used [5,11]. Strain 6 was isolated from the nor-
mal gut microbiota of a healthy broiler chicken and was
used as indicator strain because it is not able to inhibit
other C. perfringens strains and its growth is inhibited by
strain 56 [11].
Forty-five randomly chosen C. perfringens strains of
different origin were used in the perfrin PCR: ATCC3624;
NCTC3110; NCTC3180; NCTC8503; NCIB 10748; 13
strains isolated from cattle; 11 from pigs; 10 from turkeys,
three from sheep and three from humans.
C. perfringens strain CP4, a strain isolated from a broiler
suffering from necrotic enteritis, was used in Southern
Blotting experiments [14].
Agar spot test
Bacteria to be tested were grown overnight anaerobically
in Brain Heart Infusion (BHI, Oxoid, Basingstoke, UK)
broth. Lawns of bacteria were prepared by diluting the
overnight cultures in phosphate buffered saline (PBS) to
a density of McFarland 1, and 100 μL of these suspen-
sions were spread with a sterile swab on the surface of
BHI agar plates. Drops of 20 μL of the fractions withpotential antimicrobial activity (see below) were spotted
on these lawns or single colonies of C. perfringens strains
were transferred with a sterile toothpick to the agar plates.
Antimicrobial activity is shown by the absence of growth
of the bacterial lawn around the colony or on the location
of the spot.
Antimicrobial protein purification and identification
C. perfringens strain 56 was grown anaerobically in Tryptic
Soy Broth (TSB, Oxoid) for 24 h at 42 °C (800 mL). Culture
supernatant was obtained by centrifugation at 17 000 g
for 15 min at 4 °C. The supernatant was filter sterilized
(0.22 μm) and supernatant proteins were precipitated by
overnight incubation in 50% (w/v) (NH4)2SO4 (Sigma
Aldrich, St. Louis, MO, USA) at 4 °C followed by centri-
fugation at 17 000 g for 2 h at 4 °C. The precipitate was
resuspended in 5 mL of PBS and dialyzed against
10 mM Tris–HCl buffer, pH 8.5 (5 L) for 24 h at 4 °C
with 3 buffer changes. This concentrated supernatant
was tested for antimicrobial activity against C. perfrin-
gens strain 6 using the agar spot test. Antimicrobial con-
centrated supernatant was loaded onto a SP-Sepharose
cation exchange column (GE Healthcare, Little Chalfont,
Buckinghamshire, UK) in 10 mM NaOAc buffer, pH 4.
Proteins were eluted using stepwise increasing concen-
trations of NaCl (up to 1 M). To determine the anti-
microbial activity of the fractions, two-fold dilutions of
the fractions were spotted on a lawn of strain 6 in the
agar spot test (see above). The most active fractions in
the antimicrobial assay were pooled and loaded onto a
butyl Sepharose hydrophobic interaction column (GE
Healthcare) in 50 mM sodium phosphate buffer with
1 M (NH4)2SO4, pH 7.4. Proteins were stepwise eluted
from the column with decreasing concentrations of
(NH4)2SO4. The activity of the fractions was again de-
termined and the most active fraction was concentrated
and analyzed by SDS-PAGE. Precision Plus Protein
Standard, All Blue (Bio-Rad Laboratories, Hercules, CA,
USA) was used as protein marker. The protein band
was cut from the gel and subjected to in-gel protein di-
gestion with trypsin [15] followed by mass spectromet-
ric characterization. After mixing 1 μL of the digestion
mixture with 10 μL α-cyano 4-hydroxycinnamic acid
(5 mg/mL), 1 μL was spotted onto the target plate and
analyzed with the 4800 plus MALDI TOF/TOF Analyzer
(Applied Biosystems, Foster City, CA, USA). Mass spectral
data were searched against different protein databases using
an in-house MASCOT server (Matrixscience, London,
UK). A NCBI BLAST-search was done with the amino acid
sequences revealed by manual interpretation of the MS/MS
spectra [16]. The protein fragment sequences were also
compared with the genome sequence of strain 56.
Prediction of transmembrane helices was done with
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(TMHMM) [17]. Prediction of signal peptides was done
with Signal-BLAST [18] and Sigcleave [19]. ExPASy was
used [20] to determine the theoretical isoelectric point
and molecular weight.Genome sequencing of C. perfringens strain 56
5 μg of genomic DNA was extracted and purified using
Easy DNA kit (K1801, Invitrogen, Merelbeke, Belgium).
Roche GS-FLX titanium libraries were generated, using
5 μg of the purified DNA sample. The DNA was fragmen-
ted by nebulisation, followed by a double Solid Phase Re-
versible Immobilization (SPRI) bead capture size selection
with Ampure beads (Agencourt Bioscience, Beverly
Massachusetts, USA) to generate DNA fragments of
400–1.500 bp in length. Selected fragments were end-
repaired and ligated to 454 sequencing adapters. A single
stranded library was then generated according to the Roche
GS FLX Titanium General Library Preparation Method
Manual (version October 2008). This single stranded
library was used to perform an emulsion PCR according
to the Roche GS FLX titanium emPCR Method Manual
(version October 2008).
The resulting bead library was sequenced on a Roche
GS-FLX system following the GS FLX Titanium Sequen-
cing Method Manual (version October 2008). A 70 ×
75 mm picotiter plate was divided in 2 lanes using a rubber
gasket. One of the two lanes was loaded with 2 million
DNA library beads.
The Mimicking Intelligent Read Assembly package
MIRA (version 2.9.58) [21] was used to perform a de novo
genome assembly. MIRA used 550.692 of the 556.703 gen-
erated sequences to assemble 59 relevant contigs, ranging
from 226.570 to 2.627 bp. The total consensus sequence
was 3.633.567 bp, with an average sequencing coverage of
57X. The contigs were mapped against the reference
genome “Clostridium perfringens ATCC 13124 complete
genome” (gi|110798562|ref|NC_008261.1) using Projector
2 [22]. This mapping allowed for a manual scaffolding of
overlapping contigs, resulting in 29 scaffolds ranging from
481.823 to 4.838 bp. Mapping of these scaffolds against
“Clostridium perfringens ATCC 13124 complete genome”
using Projector 2 showed an almost completely closed cir-
cular genome, with only 28 small gaps (< 20.035 bp) and a
total consensus sequence of 3.290.797 bp.
All relevant scaffolds were submitted to the Rapid
Annotations using Subsystems Technology server (RAST)
[23] for a fully automated annotation of the sequences.Amino acid sequence accession number
The amino acid sequence data reported in this manu-
script are available from GenBank under accession num-
ber HQ666823.Detection of perfrin in C. perfringens strains
The presence of the perfrin gene in the 50 poultry C.
perfringens strains and 45 strains from different origin
was investigated by PCR. One colony from each strain
was suspended in 20 μL lysis buffer (0.25% SDS, 0.05 N
NaOH), heated at 95 °C for 5 min, diluted by adding
180 μL of pure water and then centrifuged at 10 000 g for
5 min. The supernatants were collected and used as the
template for PCR. The reactions were performed in a total
volume of 10 μL, containing 1 μL of lysate, 1× Biomix
(Bioline, London, UK) and 0.5 μM of primers (fw1 5′-GA
AATCTGACATAATTTTTGCTTTC-3′; fw2 5′-AATCT
TATCGTAATTCTTACTT-3′; fw3 5′-CACCTATCCTTA
TAATAGC-3′; fw4 5′-TGCCAGTAGGGGTGCTTC-3′;
rev1 5′-TTTTTAAGTTTTGTTTAACGTTTGG-3′; Rev2
5′-AACTTATAGTTAATCCAGTACC-3′; rev3 5′-TTAA
TAATAAGAAATTCTAG-3′; rev4 5′-ACCCCTATTTGC
TGCTGTC-3′). The following conditions were used: de-
naturation at 94 °C for 3 min; 30 cycles of denaturation at
94 °C for 30 s; annealing at 45 °C (fw2-rev2; fw3-rev3; fw1-
rev2) at 50 °C (fw1-rev1) or 60 °C (fw4-rev4) for 30 s; and
extension at 72 °C for 1 min; with the final extension step
at 72 °C for 5 min. PCR products were analyzed by electro-
phoresis on 1.5% agarose gels.
PFGE and southern blot analysis
PFGE and Southern Blot were performed as described in
[7], to determine whether the gene was plasmid-borne
or chromosomal. DNA plugs for PFGE were prepared
from the C. perfringens strains containing the perfrin
gene. The strains were grown in TGY and the bacterial
pellets incorporated into a final agarose concentration of
1% in PFGE certified agarose (Bio-Rad Laboratories).
Plugs were incubated overnight with gentle shaking at
37 °C in lysis buffer (0.5 M EDTA pH8.0, 2.5% (v/v) of
20% sarkosyl, 0.25% lysozyme, 0.2% deoxycholic acid)
and subsequently incubated in 2% proteinase K buffer
for 2 days at 55 °C. One third of a plug per isolate was
equilibrated in 200 μL restriction buffer at room
temperature for 20 min and then digested with 10 U of
NotI at 37 °C overnight. Electrophoresis was performed in
a 1% PFGE-certified gel and separated with the CHEF-III
PFGE system in 0.5 × Tris-borate-EDTA buffer at 14 °C at
6 V for 20 h with a ramped pulse time of 0.5 to 17.3 s. Gels
were stained in RedSafe and visualized by UV light. Mid-
Range II PFG markers were used as molecular DNA ladder.
DNA probes for all Southern blot steps were labeled by
PCR amplification in the presence of digoxigenin-11-
dUTP (DIG; Roche Applied Science) according to the
manufacturer’s recommendations. DNA probes were amp-
lified from C. perfringens strain CP4 [7,14]. DNA probes
for the perfrin gene were prepared with specific internal
primers (fw2 5′-AATCTTATCGTAATTCTTACTT-3′;
rev2 5′-AACTTATAGTTAATCCAGTACC-3′). DNA
50 kDa
37 kDa
25 kDa
20 kDa
15 kDa
10 kDa
21
Figure 1 SDS-PAGE analysis of purified perfrin from C.
perfringens strain 56. Lane 1: purified perfrin from C. perfringens
strain 56; Lane 2: Precision Plus Protein Standard, All Blue.
Timbermont et al. Veterinary Research 2014, 45:40 Page 4 of 10
http://www.veterinaryresearch.org/content/45/1/40from PFGE gels was transferred to nylon membranes.
DNA hybridizations and detection were performed by
using the DIG labeling and CSPD substrate according
to the manufacturer’s recommendations (DIG system
user’s guide for filter hybridization, Roche). For Southern
blot hybridizations, nylon membranes were prehybridized
for at least 2 h at 42 °C in hybridization solution without
labeled probe and then hybridized separately at 42 °C with
specific bacteriocin DNA probe for 16 h. The membranes
were washed at 68 °C under high-stringency conditions.
Purification of recombinant perfrin
The part of the perfrin gene encoding the 11.5 kDa active
fragment (nucleotide 301 – 621) was amplified by PCR
using the following primers: fw3 5′-CACCTATCCTTA
TAATAGC-3′ and rev3 5′-TTAATAATAAGAAATTCT
AG-3′. The PCR product was cloned into the Gateway™
entry vector pENTR/TEV/TOPO and transferred into the
Gateway™ expression vector pDEST17 according to the
manufacturer’s instructions (Invitrogen). The recombinant
protein was purified on a nickel affinity column (His
GraviTrap; GE Healthcare). This results in the 11.5 kDa
active fragment with a 6xHis tag and a Tobacco Etch Virus
(TEV)-cleavage site at the N-terminal part of the peptide.
Characterization of the antimicrobial peptide
Large amounts of perfrin and rPerfrin were purified
using the techniques outlined above. Thermal, pH and
protease stability of the purified bacteriocin and the
recombinant bacteriocin were tested. The remaining
antibacterial activity after temperature, pH and protease
treatment was determined by the agar spot test using di-
lutions of the treated (either or not recombinant) perfrin
suspensions. The activity of the treated Perfrin suspen-
sions was compared with the activity of a corresponding
control (= 100%). First, thermal stability of perfrin was
investigated by determination of the residual antibacter-
ial activity after incubation at 4, 24, 37, 42, 60, 80 and
100 °C for 10, 30 and 60 min. To evaluate the influence
of pH on activity, the perfrin suspension was adjusted to
a pH of 2.0, 4.0, 6.0, 8.0, 10.0 and 12.0 with HCl or
NaOH, mixed, incubated at room temperature for 1 h,
neutralized to pH 7, and tested for activity. Effect of
trypsin and proteinase K (Sigma) on perfrin activity was
also tested. Each enzyme was prepared at a concentra-
tion of 10 mg/mL and added to the purified bacteriocin
suspension at a final concentration of 1 and 0.1 mg/mL.
After incubation for 1 h at 37 °C, the inhibitory activity
was tested. The ability of the purified bacteriocin to inhibit
other C. perfringens strains was analyzed by the agar spot
test by spotting 20 μL drops on lawns of the 50 C. perfrin-
gens strains and compared with the antimicrobial activity
of the concentrated supernatant of C. perfringens strain 56
and of C. perfringens strain 56 itself (colony).Killing kinetics of perfrin
To determine the effect of the bacteriocin on growing
cells of a sensitive strain, an overnight culture of C. per-
fringens strain 6 was diluted in TSB and grown anaerobic-
ally at 37 °C until the absorbance reached approximately
0.1 at 600 nm. The purified bacteriocin was added and
samples were taken every hour for 8 h. PBS was added as
control. The colony forming units per mL (cfu/mL) were
determined by anaerobic incubation of 10 fold-dilutions
plated on Columbia agar plates with 5% sheep blood. The
experiment was performed in triplicate.Results
Purification and identification of the antimicrobial
peptide produced by Clostridium perfringens strain 56
Perfrin was purified by cation exchange chromatography
followed by hydrophobic interaction. The fractions with
antimicrobial activity showed a single band on SDS-
PAGE. The molecular mass of the purified bacteriocin
was approximately 12 kDa (Figure 1). The peptide mass
fingerprint and MS/MS database search against the public
protein databases did not allow us to identify the protein.
The quality of a few MS/MS spectra of tryptic peptides
was sufficient to reveal five protein fragment sequences
(Figure 2). No corresponding protein sequence was found
by a NCBI BLAST search. A search in the genome
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sequences highly similar to the five protein fragment
sequences in a hypothetical protein (22.91 kDa; 207AA).
All amino acid sequences found are situated in the
C-terminal 106 amino acids of the protein (Figure 2).
Signal-BLAST found homology in the N-terminal re-
gion with the signal sequence of Staphylococcus aureus
enterotoxin type D, suggesting a cleavage site after
amino acid at position 33 (L). Sigcleave found a signal
sequence from amino acid G88 to amino acid A100
(Figure 2). The hypothetical protein is a basic protein
with a pI of 9.91. Analysis of the amino acid sequence
using TransMembrane prediction program TMHMM
showed that the full length protein is composed of 4
transmembrane helices (Figure 3).Figure 2 Nucleotide and corresponding amino acid sequence of the 2
spectrometry are shown under the amino acid sequence (numbered from
the protein sequence are in bold type. Putative signal peptides are underli
in red, blue or pink are regions predicted by TMHMM to be located transm
bacteriocin found in the supernatant starts at amino acid position Y101.Detection of perfrin in C. perfringens strains
Of the 50 poultry derived C. perfringens strains tested,
10 strains were positive for perfrin: 9 strains isolated
from necrotic enteritis cases (netB positive) and one iso-
lated from a healthy chicken but also positive for netB
(Table 1). No perfrin-specific product was observed in
any of the 45 non-poultry derived strains, which in-
cluded netB-negative C. perfringens type A, B, C, D and
E strains isolated from cattle, sheep, pigs, and humans.
PFGE and southern blot
The PFGE profiles of the 10 C. perfringens strains positive
in the perfrin PCR revealed one to three large plasmids
ranging in size from 48–73 kb. Hybridization of the per-
frin-probe was not observed in any of the large plasmids.2.91 kDa protein. The five amino acid sequences found by mass
1 to 5, starting from the arrows). The amino acids corresponding to
ned and the putative cleavage sites are marked with an ˄. Sequences
embrane (red), intracellular (blue) or extracellular (pink). The active
TMHMM posterior probabilities for Sequence
0
0.2
0.4
0.6
0.8
1
1.2
50 100 150 200
Transmembrane Inside Outside
Figure 3 Protein profile analysis of the 22.91 kDa protein. The X-axis shows the amino acid position and the Y-axis indicates the probability
of regions being located transmembrane (red), intracellular (blue) or extracellular (pink) predicted by TMHMM. The 11.5 kDa protein starts at the
beginning of the second extracellular loop at amino acid position Y101.
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of all the strains.Purification of rperfrin
The purified rperfrin has a molecular mass of approxi-
mately 16 kDa, in accordance with the molecular mass
of perfrin added with the 6xHis tag and the TEV cleav-
age site. Purified rperfrin showed antimicrobial activity
against C. perfringens strain 6 without cleaving the
6xHis tag.Characterization of the antimicrobial peptide
Perfrin and rperfrin have the same characteristics. After
30 min at 80 °C and after 10 min at 100 °C, antimicro-
bial activity against strain 6 was no longer present. Anti-
microbial activity was most stable at neutral pH, and a
decrease was detected at pH 2 and pH 12. Complete
inactivation or significant reduction in antimicrobial
activity was observed after treatment with trypsin and
proteinase K. The antimicrobial peptide was able to in-
hibit the growth of 15 of the 50 C. perfringens strains. It
did not inhibit the growth of the producer strain, strain
56, nor did it inhibit the 9 strains that were positive for
the perfrin gene. The concentrated supernatant spotted
on a lawn also inhibited 15 of the 50 C. perfringens
strains tested but strain 56 itself (as a colony stabbed in
a lawn) was able to inhibit 41 strains.Effect of perfrin on a sensitive strain
An exponentially growing culture of the sensitive C.
perfringens strain 6 was treated with perfrin. The number
of bacteria from indicator strain 6 decreased in time
suggesting bactericidal activity (Figure 4).Discussion
The nature of the inhibitory components responsible for
the intra-species growth-inhibition in necrotic enteritis
associated C. perfringens strains was hitherto unknown.
The antibacterial peptide identified in this study is a
novel bacteriocin, referred to as perfrin, without hom-
ology with currently known bacteriocins or antimicrobial
proteins. No sequence similarity was found with a
known gene or protein in database searches. Even more,
no similarity was found with gene or protein sequences
of any of the 4 genome-sequenced C. perfringens type A
strains [24-26]. The sequenced strains are two gangrene
strains and a food poisoning strain isolated from humans
and a strain isolated from a case of bovine clostridial
abomasitis. Of the 95 C. perfringens strains from differ-
ent origin tested, 10 were positive for the perfrin gene.
These 10 strains were isolated from broilers and are all
netB-positive strains. However, netB and perfrin are not
located on the same genetic element since NetB is plas-
mid encoded [7] and perfrin not. This might be expected
since a few netB-positive strains are perfrin negative
(Table 1). One could expect that any strain in principle
benefits from being able to inhibit closely related com-
petitors by carrying and expressing the perfrin gene. The
fact that perfrin is only found in netB-positive strains
suggests that it may be important in the pathogenesis of
necrotic enteritis. Recently, indications have been obtained
that both plasmid and chromosomal genes contribute to
the pathogenesis of necrotic enteritis [27]. The strains
harboring the perfrin gene in combination with the netB
plasmid probably have a selective advantage over strains
only harboring the netB plasmid.
The newly identified bacteriocin is hypothesized to
have a signal sequence in the N-terminal region (M1 –
L33). This suggests that the protein is secreted. Sigcleave
Table 1 Broiler C. perfringens strains used in the study
Health Toxin perfrin Inhibited by
Strain Status Type netB (cpp) Cp 56 SN Perfrin Reference
1 Healthy A - - + - - [9]
2 Healthy A - - + + + [9]
3 Healthy A - - + + + [9]
4 Healthy A - - + + + [9]
5 Healthy A - - + - - [9]
6 Healthy A - - + + + [9]
7 Healthy A - - + - - [9]
8 Healthy A - - + + + [9]
9 Healthy A - - + + + [9]
10 Healthy A - - + - - [9]
11 Healthy A - - + - - [9]
12 Healthy A - - + - - [9]
13 Healthy A - - + + + [9]
15 Healthy A - - + + + [9]
16 Healthy A - - + + + [9]
17 Healthy A - - + + + [9]
18 Healthy A - - + - - [9]
19 Healthy A - - + - - [9]
20 Healthy A - - + - - [9]
21 Healthy A - - + + + [9]
22 Healthy A - - + + + [9]
23 Healthy A + + + - - [9]
24 Healthy A - - + + + [9]
25 Healthy A - - + - - [9]
26 Healthy A - - + - - [9]
27 Healthy A - - + + + [9]
28 NE A + - - - - [9]
37 NE A + - - - - [9]
38 NE A + - - - - [9]
43 NE A - - + + + [9]
48 NE A - - + - - [9]
56 NE A + + - - - [9]
58 NE A + + - - - [9]
60 NE A + - + + + [9]
61 NE A + - - - - [9]
97.78247-2 NE A - - + - - [8]
98.78718-2 NE A + - + + + [8]
99.63206-34 NE A + - + - - [8]
00.82196-2 NE A + + + - - [8]
301001-1-B1 NE A + + + - - [8]
200302-1-1-Ba NE A + + + - - [8]
75-659481-1 NE A + + - - - [8]
70292-4 NE A + + + - - [8]
75.65603-1 NE A + - + + + [8]
75.65603-2 NE A + - + - - [8]
75.65948-1 NE A + + - - - [8]
75.65948-6 NE A + + + - - [8]
97.71994-2 NE A + - + + + [8]
98.73920-13 NE A + - + + + [8]
00.71842-1 NE A + - + + + [8]
The health status of the flock they are isolated from, the toxinotype, netB and perfrin (cpp) PCR results and the antimicrobial activity of C. perfringens strain 56
(colony), the supernatant of C. perfringens strain 56 (SN) and the purified perfrin are listed.
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Figure 4 Activity of perfrin on the viability of the sensitive
C. perfringens strain 6. Results shown represent the mean of three
experiments, the bars represent the standard deviations. C. perfringens
strain 6 was grown until early logarithmic phase and PBS or perfrin
was added (0 h). Colony forming units were determined every hour
for 8 h.
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with a cleavage site after amino acid 100 and indeed all
amino acid sequences found by mass spectrometry were
situated in the last 106 amino acids (Y101 – Y206) of
the 22.91 kDa protein. A fragment starting at Y101
would have a molecular mass of 11.538 kDa which is in
accordance with the estimated molecular mass of the
purified antimicrobial peptide (Figure 1). This was con-
firmed by the antimicrobial activity of rperfrin which
starts at Y101.
The amino acid sequence of the protein indicates the
presence of four transmembrane helices (Figure 3). We
can assume that the N-terminal part (three transmem-
brane helices) of the protein is anchored in the mem-
brane and because of the internal signal sequence (G88
– A100), the active C-terminal part (Y101 – Y206) is
released. To our knowledge, this is the first time an
internal signal sequence is found in a bacteriocin.
The transmembrane helix at the C-terminal part of
the 11.5 kDa part of the protein, might suggest that the
antimicrobial peptide acts by pore formation. This is a
feature similar to those of many characterized antimicro-
bial peptides from Gram-positive bacteria [13,28]. It has
indeed been shown that the C-terminal region of class IIa
bacteriocins forms one or two helices which penetrate the
cell membrane, thereby inducing leakage and cell death
[29,30]. Moreover, perfrin has bactericidal activity (Figure 4)
and this is in accordance with pore formation.
C. perfringens strain 56 most likely produces more
bacteriocins in addition to the protein identified in this
work since the inhibitory spectrum of C. perfringens
strain 56 (41/50 strains) and that of the concentrated
supernatant and the purified bacteriocin (15/50 strains)are not identical. It is not unusual that a C. perfringens
strain produces more than 1 bacteriocin simultaneously.
As an example, Higa et al. [31] showed that C. perfrin-
gens SN-17 produced two bacteriocins in succession.
Moreover, it was also shown that these bacteriocins have
different inhibitory spectra. To detect the additional
antimicrobial factor(s), the purification protocol needs to
be adapted since these factors are not present in the
concentrated supernatant prepared in the present study.
There are various possibilities: maybe these bacteriocins
are only secreted in co-cultures of the producing strain
and a sensitive strain. This is a common feature among
Lactobacillus plantarum bacteriocinogenic strains [32,33].
The bacteriocin might be adsorbed at the surface of the
producing strain and a shift in pH could result in the re-
lease of the bacteriocin as demonstrated for different bac-
teriocins from lactic acid bacteria [34]. Another possibility
is that the bacteriocin is secreted as inactive precursor and
it needs to be processed by proteases to have antibacterial
activity [35].
C. perfringens strain 56 and the 9 other C. perfringens
strains that are positive for the perfrin gene are not sen-
sitive to their own bacteriocin (Table 1). Genes encoding
membrane-associated molecules that confer a degree of
specific protection upon the producer strain have been
found. For example, Diep et al. [36] showed that an
immunity protein prevents Lactococcus lactis from being
killed by its permeabilizing peptide-bacteriocin, lacto-
coccin A, by formation of a strong complex between the
receptor proteins and the bacteriocin. Moreover, it was
shown that the immunity protein is only expressed if
mature bacteriocin is produced or if it is present in the
environment [36]. In the case of perfrin, it is tempting
to speculate that protection in the producer strain may
be afforded by the N-terminal fragment, which would
guarantee a perfect match between bacteriocin produc-
tion and protection. This, however, needs to be further
investigated.
In conclusion, a novel bacteriocin called perfrin was
purified from the supernatant of a necrotic enteritis indu-
cing C. perfringens strain and characterized. It is the
11.5 kDa C-terminal part of a 23 kDa novel protein
without any homology with currently known bacteriocins,
suggesting that a new family of bacteriocins is discovered.
Until now, the bacteriocin is only detected in netB positive
C. perfringens strains, suggesting it might be of importance
in the pathogenesis of necrotic enteritis.
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